Publications by authors named "Lika Apriani"

17Publications

IL-32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines.

J Leukoc Biol 2020 01 4;107(1):113-118. Epub 2019 Aug 4.

Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS), and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/JLB.4AB0219-071RDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972663PMC
January 2020

Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.

J Infect Dis 2020 Mar;221(8):1351-1360

Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiz168DOI Listing
March 2020

Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review.

Eur Respir J 2019 04 18;53(4). Epub 2019 Apr 18.

Montreal Chest Institute, McGill University Montreal, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01789-2018DOI Listing
April 2019

Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.

J Glob Antimicrob Resist 2019 03 29;16:170-177. Epub 2018 Aug 29.

Infectious Disease Research Center, Faculty of Medicine, Universitas Padjadjaran, Eijkman 38, Bandung 40161, Indonesia; Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital, Pasir Kaliki 38, Bandung 40161, Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgar.2018.08.018DOI Listing
March 2019

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

N Engl J Med 2018 08;379(5):440-453

From the Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre Research Institute (D.M., A.T., C.V., K.H., M.-J.D., P.Z.L., K.S., A.B.), and the Department of Epidemiology and Biostatistics (D.M., A.B.), McGill University, Montreal, the Faculty of Medicine and Dentistry, University of Alberta, Edmonton (R.L.), the Faculty of Medicine, University of Saskatchewan, Saskatoon (V.H.), and the BC Centre for Disease Control and the University of British Columbia, Vancouver (K.E., V.J.C.) - all in Canada; Centre National Hospitalier Universitaire de Pneumo-Phtisiologie, Cotonou, Benin (M.A., M.G.); the Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia (R.R., L.A., R.C.K.); State University of Rio de Janeiro (A.T.), Programa Academico de Tuberculose-Faculdade de Medicina, Universidade Federal do Rio de Janeiro-Rede TB (A.K.), and National Institute of Infectious Diseases Evandro Chagas (V.R.) - all in Rio de Janeiro; Service de Pneumophtisiologie, Hôpital National Ignace Deen, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea (O.S., B.B., A.C.); Korean Institute of Tuberculosis, Seoul, South Korea (H.K.); Komfo Anokye Teaching Hospital, Kumasi, Ghana (J.O.B., I.B.); University of New South Wales (G.B.M.) and University of Sydney (H.G.), Sydney; Centre for International Health, University of Otago, Dunedin, New Zealand (P.C.H.); and the Department of Medicine, King Saud University, King Abdulaziz Medical City, Riyadh, Saudi Arabia (H.A.-J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714283DOI Listing
August 2018

Safety and Side Effects of Rifampin versus Isoniazid in Children.

N Engl J Med 2018 08;379(5):454-463

From Service de Pneumophtisiologie, Hôpital National Ignace Deen, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea (T.D., O.S.); the Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre Research Institute (T.D., A.T., D.Z., C.V., F.F., K.H., P.Z.L., K.S., A.B., D.M.), the Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health (A.B.), and Montreal Children's Hospital (D.Z.), McGill University, Montreal, the TB Program Evaluation and Research Unit, University of Alberta, Edmonton (R.L.), and the British Columbia Centre for Disease Control and University of British Columbia, Vancouver (K.E.) - all in Canada; Centre National Hospitalier Universitaire de Pneumo-Phtisiologie, Cotonou, Benin (M.A., M.G.); Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia (R.R., D.A.W., L.A.); the Social Medicine Institute, Rio de Janeiro State University, Rio de Janeiro (A.T.); Komfo Anokye Teaching Hospital, Kumasi, Ghana (J.O.B.); the University of New South Wales, Sydney (G.B.M.); and the Centre for International Health, University of Otago, Dunedin, New Zealand (P.C.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714284DOI Listing
August 2018

Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia.

Trans R Soc Trop Med Hyg 2017 02;111(2):81-89

Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Dunedin 9054, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/trstmh/trx015DOI Listing
February 2017

Diagnostic value of antibody responses to multiple antigens from Mycobacterium tuberculosis in active and latent tuberculosis.

Diagn Microbiol Infect Dis 2015 Nov 29;83(3):278-85. Epub 2015 Jul 29.

Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, 21 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Miyagi, Japan; Division of Disaster-related Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2015.07.021DOI Listing
November 2015

Quality and reporting of publications by Indonesian researchers: a literature survey.

J Evid Based Med 2014 Aug;7(3):163-71

Community Medicine Department, Faculty of Medicine, University of Indonesia, Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jebm.12112DOI Listing
August 2014

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.

Lancet Infect Dis 2013 Jan 25;13(1):27-35. Epub 2012 Oct 25.

Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung, Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(12)70264-5DOI Listing
January 2013

Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia.

J Infect Dis 2010 Feb;201(4):553-7

Department of Clinical Pathology, Hasan Sadikin Hospital, Medical Faculty, Universitas Padjadjaran, Bandung, Indonesia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/650311DOI Listing
February 2010

Improving diagnosis of pulmonary tuberculosis among HIV/AIDS patients: literature review and experience in a teaching hospital in Indonesia.

Acta Med Indones 2009 Jul;41 Suppl 1:57-64

On Behalf of IMPACT (Integrated Management for Prevention and Control and Treatment of HIV/ AIDS) Project, Bandung, Indonesia, Health Research Unit, Faculty of Medicine, Padjadjaran University/Hasan Sadikin Hospital. Jl. Pasirkaliki no. 190, Bandung 40151, Indonesia.

View Article

Download full-text PDF

Source
July 2009